Chronic treatment with antidepressants prevents the inhibitory effect of small doses of apomorphine on dopamine synthesis and motor activity.
D015102:3,4-Dihydroxyphenylacetic Acid / Q000032:analysis; D000639:Amitriptyline / Q000494:pharmacology; D000818:Animals; D000929:Antidepressive Agents, Tricyclic / Q000494:pharmacology*; D001058:Apomorphine / Q000037:antagonists & inhibitors*; D002421:Caudate Nucleus / Q000032:analysis; D002746:Chlorpromazine / Q000494:pharmacology; D004298:Dopamine / Q000096:biosynthesis*; D007099:Imipramine / Q000494:pharmacology; D008297:Male; D008803:Mianserin / Q000494:pharmacology; D009043:Motor Activity / Q000187:drug effects*; D051381:Rats; D011954:Receptors, Dopamine / Q000187:drug effects
D000929:Antidepressive Agents, Tricyclic; D011954:Receptors, Dopamine; D015102:3,4-Dihydroxyphenylacetic Acid; D000639:Amitriptyline; D008803:Mianserin; D001058:Apomorphine; D007099:Imipramine; D002746:Chlorpromazine; D004298:Dopamine